dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
Published 4 years ago • 147 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
1:20
dr. ahmed on remaining questions with tucatinib in breast cancer brain metastases
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
5:21
managing brain metastases in breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
5:21
breast cancer awareness month | uc san diego oncologist discusses concerns and prevention
-
1:51
dr. o'shaughnessy on breast cancer subtype-specific cytotoxic agents
-
4:02
the spectrum of hr breast cancer: approaching treatment
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
17:38
2021 west oncology | breast cancer | update on brain metastases
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
1:45
dr. chien on tucatinib in her2 breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
9:35
neratinib in her2 breast cancer
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
1:45
dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer